Choose a Section
Most recent by Danielle M. Blais, PharmD, BCPS
SPONSORED CONTENT
April 01, 2014
4 min read
Save
Cangrelor: Not the CHAMPION we hoped for
In the past decade, patient outcomes after PCI have improved considerably with the advent of the oral P2Y12 receptor antagonists clopidogrel, prasugrel and ticagrelor.
SPONSORED CONTENT
March 01, 2011
5 min read
Save
ACE inhibitors and angiotensin receptor blockers: To hold or not to hold for IV contrast?
Contrast-induced nephrotoxicity is a significant complication that occurs in patients receiving iodinated contrast media for coronary angiography.